Xelleratherapeutics - Latest News2026-07-19T07:28:24+00:00urn:uuid:b8d3e277-83ad-d1b9-4bcb-275aa435ef59Xellera Therapeutics Expands Cell Sorting Solutions for Advanced Therapy Developmenturn:uuid:bde25c18-d857-898c-3201-79ee29e7c0f72026-06-30T05:58:21+00:00Pharmacopeia Compliance: A Key Pillar in Ensuring Safe and Effective Medicinesurn:uuid:9afac8ef-de48-1ca9-b5cd-744d9293fb912026-03-31T07:40:16+00:00Advancing Regenerative Medicine with MSC Manufacturing Solutionsurn:uuid:271cdaa9-7d58-19c7-f55e-cb4fe1db2c412026-03-20T06:14:49+00:00GMP Standards Strengthen the Future of Biopharmaceutical Manufacturingurn:uuid:7fdc3d9e-36f4-8c81-1737-2bcdf35bae842026-02-24T09:14:52+00:00Advanced Therapy Products Driving the Next Era of Innovative Healthcare Solutionsurn:uuid:c3e193da-5bf5-9209-7178-959b909a3a3b2026-01-01T12:38:14+00:00Understanding Endotoxins: Why They Matter in Biopharmaceutical Manufacturingurn:uuid:989a2840-5847-5e45-1d45-c01b127d9ad22025-11-26T10:22:49+00:00Advancing Biopharma Safety and Longevity with Next-Generation Cryogenic Storage Solutionsurn:uuid:c6fb9b9c-2fd3-0804-b0f9-2650da79e7df2025-10-22T11:59:24+00:00Dendritic Cells: Pioneering the Next Generation of Immunotherapy and Vaccine Developmenturn:uuid:1e3254f0-f696-6174-94c6-4ac3958b8b232025-09-25T11:52:37+00:00Xellera Therapeutics Advances Diagnostic and Therapeutic Solutions for Mycoplasma pneumoniaeurn:uuid:e5cd67ea-86ff-3ba4-0bec-1dc7e590c7a32025-08-21T06:41:44+00:00Advances Molecular Diagnostics with Enhanced Polymerase Chain Reaction (PCR) Technologyurn:uuid:61ed8f84-fe3f-c152-c0c5-87fe4d0a23e52025-07-14T07:40:34+00:00Xellera Therapeutics Achieves New GMP Milestone to Advance Quality and Compliance in Therapeutic Manufacturingurn:uuid:eec345bd-b57f-5afb-3055-4c2acafa0aa72025-06-25T08:21:01+00:00